Sermorelin is a synthetic GHRH(1-29) amide analogue. It represents the active 1-29 fragment of growth-hormone-releasing hormone, which makes it a straightforward reference for GHRH receptor and endocrine signalling studies.
The value of Sermorelin is comparison. Customers often look at it alongside modified GRF(1-29), CJC-1295 no-DAC, CJC-1295 with DAC, and Tesamorelin to understand how sequence modifications change receptor-pathway behaviour and marker readouts.
This product is best understood as a clean GHRH-fragment reference. The specification table covers sequence, mass, formula, purity, solubility, storage, and lot-level analytical information.
The references below are starting points for the mechanisms discussed here. The specification table on this page covers identity, formula, molecular mass, physical form, solubility, storage, and lot-level analytical information.
References
Research-use notice: Supplied strictly for lawful research, laboratory, analytical, educational, or R&D purposes where permitted by applicable law. Not for human or animal use, consumption, diagnosis, treatment, food, supplement, cosmetic, veterinary, or similar end use.
